Erratum: In vitro and in vivo synergistic antitumor activity of the combination of BKM120 and erlotinib in head and neck cancer: Mechanism of apoptosis and resistance (Molecular Cancer Therapeutics (2017) 16 (729–738) DOI: 10.1158/1535-7163.MCT-16-0683)

Abu Syed Md Anisuzzaman; Abedul Haque; Dongsheng Wang; Mohammad Aminur Rahman; Chao Zhang; Zhengjia Chen; Zhuo Georgia Chen; Dong M. Shin; A. R.M. Ruhul Amin

doi:10.1158/1535-7163.MCT-20-0602

Erratum: In vitro and in vivo synergistic antitumor activity of the combination of BKM120 and erlotinib in head and neck cancer: Mechanism of apoptosis and resistance (Molecular Cancer Therapeutics (2017) 16 (729–738) DOI: 10.1158/1535-7163.MCT-16-0683)

Abu Syed Md Anisuzzaman, Abedul Haque, Dongsheng Wang, Mohammad Aminur Rahman, Chao Zhang, Zhengjia Chen, Zhuo Georgia Chen, Dong M. Shin, A. R.M. Ruhul Amin

Hematopathology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original version of this article (1), an IHC image (expression of p-EGFR control) was mistakenly used twice in Fig. 3B. The appropriate BKM panel in the p-EGFR column has replaced the duplicated panel. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Original language	English (US)
Pages (from-to)	1955
Number of pages	1
Journal	Molecular cancer therapeutics
Volume	19
Issue number	9
DOIs	https://doi.org/10.1158/1535-7163.MCT-20-0602
State	Published - Sep 1 2020

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1535-7163.MCT-20-0602

Fingerprint

Dive into the research topics of 'Erratum: In vitro and in vivo synergistic antitumor activity of the combination of BKM120 and erlotinib in head and neck cancer: Mechanism of apoptosis and resistance (Molecular Cancer Therapeutics (2017) 16 (729–738) DOI: 10.1158/1535-7163.MCT-16-0683)'. Together they form a unique fingerprint.

Cite this

Anisuzzaman, A. S. M., Haque, A., Wang, D., Rahman, M. A., Zhang, C., Chen, Z., Chen, Z. G., Shin, D. M., & Ruhul Amin, A. R. M. (2020). Erratum: In vitro and in vivo synergistic antitumor activity of the combination of BKM120 and erlotinib in head and neck cancer: Mechanism of apoptosis and resistance (Molecular Cancer Therapeutics (2017) 16 (729–738) DOI: 10.1158/1535-7163.MCT-16-0683). Molecular cancer therapeutics, 19(9), 1955. https://doi.org/10.1158/1535-7163.MCT-20-0602

Erratum: In vitro and in vivo synergistic antitumor activity of the combination of BKM120 and erlotinib in head and neck cancer: Mechanism of apoptosis and resistance (Molecular Cancer Therapeutics (2017) 16 (729–738) DOI: 10.1158/1535-7163.MCT-16-0683). / Anisuzzaman, Abu Syed Md; Haque, Abedul; Wang, Dongsheng et al.
In: Molecular cancer therapeutics, Vol. 19, No. 9, 01.09.2020, p. 1955.

Research output: Contribution to journal › Comment/debate › peer-review

Anisuzzaman, ASM, Haque, A, Wang, D, Rahman, MA, Zhang, C, Chen, Z, Chen, ZG, Shin, DM & Ruhul Amin, ARM 2020, 'Erratum: In vitro and in vivo synergistic antitumor activity of the combination of BKM120 and erlotinib in head and neck cancer: Mechanism of apoptosis and resistance (Molecular Cancer Therapeutics (2017) 16 (729–738) DOI: 10.1158/1535-7163.MCT-16-0683)', Molecular cancer therapeutics, vol. 19, no. 9, pp. 1955. https://doi.org/10.1158/1535-7163.MCT-20-0602

Anisuzzaman ASM, Haque A, Wang D, Rahman MA, Zhang C, Chen Z et al. Erratum: In vitro and in vivo synergistic antitumor activity of the combination of BKM120 and erlotinib in head and neck cancer: Mechanism of apoptosis and resistance (Molecular Cancer Therapeutics (2017) 16 (729–738) DOI: 10.1158/1535-7163.MCT-16-0683). Molecular cancer therapeutics. 2020 Sep 1;19(9):1955. doi: 10.1158/1535-7163.MCT-20-0602

Anisuzzaman, Abu Syed Md ; Haque, Abedul ; Wang, Dongsheng et al. / Erratum : In vitro and in vivo synergistic antitumor activity of the combination of BKM120 and erlotinib in head and neck cancer: Mechanism of apoptosis and resistance (Molecular Cancer Therapeutics (2017) 16 (729–738) DOI: 10.1158/1535-7163.MCT-16-0683). In: Molecular cancer therapeutics. 2020 ; Vol. 19, No. 9. pp. 1955.

@article{19c8111b44224e06a3b6d7a1290495c3,

title = "Erratum: In vitro and in vivo synergistic antitumor activity of the combination of BKM120 and erlotinib in head and neck cancer: Mechanism of apoptosis and resistance (Molecular Cancer Therapeutics (2017) 16 (729–738) DOI: 10.1158/1535-7163.MCT-16-0683)",

abstract = "In the original version of this article (1), an IHC image (expression of p-EGFR control) was mistakenly used twice in Fig. 3B. The appropriate BKM panel in the p-EGFR column has replaced the duplicated panel. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.",

author = "Anisuzzaman, {Abu Syed Md} and Abedul Haque and Dongsheng Wang and Rahman, {Mohammad Aminur} and Chao Zhang and Zhengjia Chen and Chen, {Zhuo Georgia} and Shin, {Dong M.} and {Ruhul Amin}, {A. R.M.}",

note = "Publisher Copyright: {\textcopyright} 2020 American Association for Cancer Research.",

year = "2020",

month = sep,

day = "1",

doi = "10.1158/1535-7163.MCT-20-0602",

language = "English (US)",

volume = "19",

pages = "1955",

journal = "Molecular cancer therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "9",

}

TY - JOUR

T1 - Erratum

T2 - In vitro and in vivo synergistic antitumor activity of the combination of BKM120 and erlotinib in head and neck cancer: Mechanism of apoptosis and resistance (Molecular Cancer Therapeutics (2017) 16 (729–738) DOI: 10.1158/1535-7163.MCT-16-0683)

AU - Anisuzzaman, Abu Syed Md

AU - Haque, Abedul

AU - Wang, Dongsheng

AU - Rahman, Mohammad Aminur

AU - Zhang, Chao

AU - Chen, Zhengjia

AU - Chen, Zhuo Georgia

AU - Shin, Dong M.

AU - Ruhul Amin, A. R.M.

PY - 2020/9/1

Y1 - 2020/9/1

N2 - In the original version of this article (1), an IHC image (expression of p-EGFR control) was mistakenly used twice in Fig. 3B. The appropriate BKM panel in the p-EGFR column has replaced the duplicated panel. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

AB - In the original version of this article (1), an IHC image (expression of p-EGFR control) was mistakenly used twice in Fig. 3B. The appropriate BKM panel in the p-EGFR column has replaced the duplicated panel. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

UR - http://www.scopus.com/inward/record.url?scp=85100578832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85100578832&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-20-0602

DO - 10.1158/1535-7163.MCT-20-0602

M3 - Comment/debate

C2 - 32879030

AN - SCOPUS:85100578832

SN - 1535-7163

VL - 19

SP - 1955

JO - Molecular cancer therapeutics

JF - Molecular cancer therapeutics

IS - 9

ER -

Erratum: In vitro and in vivo synergistic antitumor activity of the combination of BKM120 and erlotinib in head and neck cancer: Mechanism of apoptosis and resistance (Molecular Cancer Therapeutics (2017) 16 (729–738) DOI: 10.1158/1535-7163.MCT-16-0683)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this